Penny stocks, you either love them or you hate them. One of the obvious draws of these stocks trading for under $5 per …
Last September, I wrote an article on VolitionRx’s (NYSEMKT:VNRX) potential to revolutionize cancer screening. Since then, the company has continued to show promising …
A very important shot was fired last week in the battle for the colorectal cancer diagnostics market. Cancer diagnostics minnow VolitionRx (OTCQB:VNRX) announced …
